BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.343
+0.043 (1.87%)
Dec 27, 2024, 2:21 PM EST - Market open
BioCardia Stock Forecast
BCDA's stock price has decreased by -74.87% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioCardia stock has a target of 25, which predicts an increase of 967.01% from the current stock price of 2.34.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for BioCardia is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +967.01% | Dec 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +967.01% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +967.01% | Oct 28, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +967.01% | Aug 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $25 | Strong Buy | Maintains | $4 → $25 | +967.01% | Aug 16, 2024 |
Financial Forecast
Revenue This Year
102.00K
from 477.00K
Decreased by -78.62%
Revenue Next Year
102.00K
from 102.00K
EPS This Year
-3.59
from -8.19
EPS Next Year
-1.24
from -3.59
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 105,000 | 105,000 | 105,000 | ||
| Avg | 102,000 | 102,000 | 102,000 | ||
| Low | 98,000 | 98,000 | 98,000 |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -78.0% | 2.9% | 2.9% | ||
| Avg | -78.6% | - | - | ||
| Low | -79.5% | -3.9% | -3.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -3.70 | -1.28 | -1.40 | ||
| Avg | -3.59 | -1.24 | -1.36 | ||
| Low | -3.45 | -1.20 | -1.30 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.